Merck Expands NJ Pharma Lab with Foreign-Trade Zone Perks
Published Date: 4/14/2025
Notice
Summary
Merck, Sharp & Dohme LLC wants to expand their Rahway, New Jersey facility to make new pharmaceutical products for diseases like cancer and infections using special foreign materials. This change lets them save on import duties and speed up research. Public comments are open until May 27, 2025, so folks can share their thoughts before the plan moves forward.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in